Financial reports
ARS
2023 FY
Annual report to shareholders
25 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q1
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
Current reports
8-K/A
Consolidated Financial Statements
17 Apr 24
8-K
Other Events
22 Mar 24
8-K
Other Events
29 Feb 24
8-K
Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
22 Feb 24
8-K
Departure of Directors or Certain Officers
13 Feb 24
8-K
Completion of Acquisition or Disposition of Assets
6 Feb 24
8-K
Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
8 Jan 24
8-K
Veracyte Announces Third Quarter 2023 Financial Results
7 Nov 23
8-K
Veracyte Announces Second Quarter 2023 Financial Results
8 Aug 23
8-K
Departure of Directors or Certain Officers
9 Jun 23
Registration and prospectus
424B7
Prospectus with selling stockholder info
22 Mar 24
424B7
Prospectus with selling stockholder info
29 Feb 24
S-8
Registration of securities for employees
29 Feb 24
S-3ASR
Automatic shelf registration
29 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
DEFA14A
Additional proxy soliciting materials
1 Jun 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
PRE 14A
Preliminary proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
Other
UPLOAD
Letter from SEC
20 Sep 21
CORRESP
Correspondence with SEC
9 Sep 21
UPLOAD
Letter from SEC
27 Aug 21
SEC STAFF
SEC staff action: Order
20 Feb 20
SEC STAFF
SEC staff action: Order
10 Feb 20
SEC STAFF
SEC staff action: Order
4 Jun 19
SEC STAFF
SEC staff action: Order
24 May 19
CT ORDER
Confidential treatment order
11 Mar 19
EFFECT
Notice of effectiveness
14 May 18
CORRESP
Correspondence with SEC
9 May 18